Back to Search
MARK BUYYOUNOUSKI, M.D.
M.D.
Radiation Oncology Physician
NPI: 1912927021IndividualAccepts Medicare
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
MD4211507(PA)
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
MD421507(PA)C55796(CA)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
RUTGERS NEW JERSEY MEDICAL SCHOOL
Class of 2000
Research & Publications (20)
Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy.
PMID 17919840·Int J Radiat Oncol Biol Phys·2008
8-other
Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer.
PMID 16169682·Int J Radiat Oncol Biol Phys·2005
4-observational
Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation.
PMID 15817330·Int J Radiat Oncol Biol Phys·2005
8-other
FDG PET imaging of signet-ring cell adenocarcinoma of the stomach.
PMID 15647683·Clin Nucl Med·2005
5-case
The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
PMID 15275723·Int J Radiat Oncol Biol Phys·2004
8-other
Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment.
PMID 14967429·Int J Radiat Oncol Biol Phys·2004
8-other
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
PMID 19394158·Int J Radiat Oncol Biol Phys·2010
6-review
Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.
PMID 19240249·Cancer Prev Res (Phila)·2009
8-other
Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
PMID 19111362·Radiother Oncol·2009
3-trial
RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.
PMID 18947938·Int J Radiat Oncol Biol Phys·2009
8-other
Does treatment duration affect outcome after radiotherapy for prostate cancer?
PMID 18472368·Int J Radiat Oncol Biol Phys·2008
8-other
Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens.
PMID 18289645·Urology·2008
8-other
Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?
PMID 18279939·Urology·2008
8-other
A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant.
PMID 18207665·Int J Radiat Oncol Biol Phys·2008
4-observational
How can men destined for biochemical failure after androgen deprivation and radiotherapy be identified earlier?
PMID 18164854·Int J Radiat Oncol Biol Phys·2008
8-other
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer.
PMID 17968996·Cancer·2008
4-observational
Percentage of biopsy cores positive for malignancy and biochemical failure following prostate cancer radiotherapy in 3,264 men: statistical significance without predictive performance.
PMID 17967518·Int J Radiat Oncol Biol Phys·2008
4-observational
Prostate cancer risk assessment program: a 10-year update of cancer detection.
PMID 17868726·J Urol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 PASTEUR DR
STANFORD, CA 94305 - Phone
- (650) 723-4000
Quick Facts
- NPI
- 1912927021
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile